5.9800.33% ( -0.020 )
Closed: Oct 12, 16:00:00 (EDT)Current ValuationThe current P/E ratio is 14.77, within the reasonable range, cheaper than 21.07% of the time in the past 1 years, and the industry ranks 9/54, the industry Median -0.24.
14.77xP/E
$5.98Stock price
$0.40Earnings per share
14.77xP/E
Stock price$5.98Earnings per share$0.40
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 9.27x
- Typical range
- 7.78x–14.82x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
050100150200
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
ULUSUnilever | 12.77x | 17.25% | $137.27B |
BDRFYUSBeiersdorf | 17.70x | -- | $19.24B |
NATRUSNatures Sunshine | 12.36x | 0.47% | $223.64M |
NAGEUSNiagen Bioscience | 13.01x | 42.00% | $208.10M |
FTLFUSFitLife Brands | 13.91x | 37.30% | $86.68M |
LFVNUSLifevantage | 14.77x | 51.25% | $74.91M |
AXILUSAXIL Brands | 13.83x | 112.12% | $38.55M |
UGUSUnited-Guardian | 12.86x | -- | $31.70M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
